Telix Pharmaceuticals Limited
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $277.3M
Liabilities Breakdown FY2023
Total Liabilities: $174.6M
Asset Breakdown
Total Assets: $277.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $84.3M | 30.4% |
| Accounts Receivable | $44.0M | 15.9% |
| Inventory | $12.7M | 4.6% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $136.2M | 49.1% |
Liabilities Breakdown
Total Liabilities: $174.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $54.3M | 31.1% |
| Long-Term Debt | $5.9M | 3.4% |
| Other Liabilities | $114.3M | 65.5% |